NRx Pharmaceuticals, HOPE Therapeutics sign binding LOI with Neurospa
HOPE Therapeutics, wholly owned by NRx Pharmaceuticals (NRXP), announced signing of a binding Letter of Intent, LOI, to acquire a majority ...
ETF Daily News5d
NRx Pharmaceuticals (NASDAQ:NRXP) Earns “Buy” Rating from D. Boral Capital
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports.
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
Company reports fourth quarter and full year 2024 XHANCE net revenue of $22.4 million and $78.2 million, increases of 13% and 10% compared to ...
Wall Street Journal3d
NRX Pharmaceuticals Inc. Wt
$ 0.07 USD-0.01-7.47% ...
Yahoo Finance4d
NRx Pharmaceuticals, Inc. (NRXP)
TVGN Tevogen Bio Holdings Inc.